Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:30 AM
Ignite Modification Date:
2025-12-25 @ 2:30 AM
NCT ID:
NCT02869334
Eligibility Criteria:
Inclusion Criteria:
* Age 18-55
* Primary diagnosis of Schizophrenia or schizoaffective disorder
* English fluency
* Willing/capable to provide informed consent
* Auditory tone matching deficits
* Receiving stable doses of antipsychotic medication(s) for at least 2 weeks
* IQ\>75
Exclusion Criteria:
* Serious neurological disorder or medical condition/ treatment known to affect the brain. Neurological Disorder that affects the central nervous system (CNS), such as epilepsy, neurodegenerative disorders, movement disorders and sensory disorders.
* Current or past history (within the last 6 months) of substance abuse or dependence (excluding nicotine)
* Pregnancy or breastfeeding
* Taking anticholinergic medication (e.g. Cogentin, Thorazine, Clozaril, thioridazine)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
55 Years
Study:
NCT02869334
Study Brief:
Protocol Section:
NCT02869334